Gene Query: PEX26

Dataset Description Geneva Score
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 57.5
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 57.5
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 31.17
Effect of BMP inhibition or stimulation of primary human keratinocytes 31.17
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 30.79
Genome wide expression change in LCC2 and MCF-7 cells 30.22
The effect of PPARG inhibition on human angiomyolipoma cells 29.97
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 25.34
Gene expression changes upon drug withdrawal (Mel888 cell line) 25.0
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 22.87
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 21.11
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 21.11
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 20.85
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 20.5
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 19.15
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 18.92
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 18.9
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 18.25
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 17.94
RIG-I and MDA5 fRIP during KSHV lytic reactivation 17.12
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 16.73
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 16.47
RNA m5C Methylation in breast cancer using MeRIP-Seq 16.41
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 16.12
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 15.64
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 15.37
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 15.23
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 14.4
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.74
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 13.66
circRNA-sequencing 13.46
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 13.34
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 13.34
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 13.12
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 12.98
MYC dependent mRNA translation shapes gene expression and cell biology 12.72
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 12.46
Human embryonic stem cells in E8 and AKIT culture medium 12.46
Triple vectors expand AAV transfer capacity in the retina 12.14
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 11.96
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 11.96
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 11.62
Global response to chemotherapy-induced apoptosis 11.55
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 11.47
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 11.41
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 11.41
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 11.39
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 11.3
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 11.26
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.07
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.07
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 11.03
Mitochondrial dsRNA triggers antiviral signalling in humans 11.01
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 10.66
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.08
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 10.01
HEXIM1 is induced by DHODH inhibition to suppress melanoma 9.95
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 9.95
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 9.75
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.69
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 9.67
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 9.66
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 9.58
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.55
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 9.53
Comparison of microRNA Profiling Platforms (HTS) 9.52
Comparison of microRNA Profiling Platforms 9.52
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 9.51
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 9.32
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 9.25
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 9.15
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 9.01
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 9.01
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 9.01
RNA polymerase in pre-B-ALL cell lines 8.77
Genome wide expression change by RNF168 knocking down in MCF-7 cells 8.6
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.55
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 8.52
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 8.49
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 8.4
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.21
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 8.18
METTL3 promotes translation in human cancer cells 8.16
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 8.15
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 8.06
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 8.04
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 7.97
Transcriptome of U251 cells overexpression complement component 7 7.95
HEK293 Heat-shock experiment 7.87
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 7.85
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 7.85
DART-seq: an antibody-free method for global m6A detection 7.68
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 7.62
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 7.61
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.47
Genome wide expression change by RNF168 knocking down in NEC cells 7.42
CROP-Seq in Primary Human T Cells 7.37
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 7.37
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 7.36
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.35
Global analysis of enhancer targets: Mosaic-seq 7.26
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 7.19
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 7.15
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 7.15
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 7.14
RNA-seq of Single-Cell Genotyping of Transcriptomes 7.07
Single-Cell Genotyping of Transcriptomes 7.07
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 7.04
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 7.04
HNF1A deficiency impairs β-cell fate, granule maturation and function 7.0
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 6.96
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 6.96
Targeting MTHFD2 in Acute Myeloid Leukemia 6.9
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 6.9
Human HAP1 cells before and after nutrient deprivation 6.9
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6.87
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.86
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.86
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.8
Reassessment of Exosome Composition 6.76
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 6.73
Identification of HOXB13 target genes responsive to BET inhibitors 6.63
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 6.47
Differential expression of genes in AD169-infected MRC5. 6.44
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 6.43
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 6.41
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.4
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 6.39
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.28
Exploring the RNA landscape of endothelial exosomes 6.25
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 6.23
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.22
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 6.21
4sUDRB-seq: measuring transcription elongation and initiation genomewide 6.13
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.99
RNAseq Analysis in glioblastoma cells treated with Mepazine 5.98
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 5.96
RNA sequencing of BT142 and TS603 cell lines 5.96
Identification of renal resident macrophages across species 5.92
Overexpression of NFIB and YBX1 in MCF-7 cells 5.9
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 5.87
RNA-Seq with and without RNase treatment in PCa cell lines 5.86
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 5.83
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 5.83
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.82
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 5.81
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 5.81
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.77
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 5.75
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 5.73
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.72
Capturing the Interactome of Newly Transcribed RNA 5.72
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 5.71
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 5.71
Functional role of CPPED1 in trophoblasts. 5.68
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.65
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 5.63
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 5.61
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 5.61
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.6
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 5.57
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 5.56
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 5.56
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 5.54
Peptidomimetic blockade of MYB in acute myeloid leukemia 5.54
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 5.53
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 5.51
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.5
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 5.48
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 5.45
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.44
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.43
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 5.38
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 5.32
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 5.32
PTHrP overexpression in MCF7 cells 5.28
Landscape and variation of RNA secondary structure across the human transcriptome 5.27
Identification of Atrial Fibrillation associated genes and functional non-coding variants 5.22
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 5.21
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 5.2
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.19
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.19
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 5.18
Systematic discovery of endogenous human ribonucleoprotein complexes 5.17
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 5.17
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.17
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.16
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.16
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 5.16
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 5.15
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 5.12
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.11
miR941 overexpression experiment 5.11
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 5.08
Transcriptomic analyssis following EHMT1/2 inhibition 5.06
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 5.04
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.01
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.0
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 4.98
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 4.98
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 4.97
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 4.96
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 4.95
RNA-seq analyisis of PUM2 knockout cells 4.92
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.92
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.9
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 4.9
TGF-β regulation of miRNA expression in pancreatic cancer 4.89
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.86
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 4.84
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.83
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.81
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.81
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 4.8
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 4.79
Transcriptomic analysis of the HOTAIR-regulated genes 4.78
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 4.69
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.69
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 4.68
RNA-seq of YB5 cells treated with Proscillaridin A 4.68
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 4.68
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 4.65
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 4.64
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 4.64
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 4.63
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.63
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.63
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 4.62
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 4.61
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.59
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.59
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 4.53
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.51
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 4.5
DRB/GRO-Seq -/+ UV 4.49
MicroRNA-125a-5p overexpression in human macrophages 4.47
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.47
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.47
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 4.45
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 4.45
Mapping interactions for the TNIP2 hub protein 4.44
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 4.43
NHLRC1 re-expression in cancer cells 4.4
Transcriptomic analysis of human tonsillar TFH subsets 4.4
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 4.35
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.35
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.35
Genome-wide identification of cancer-specific alternative splicing in circRNA 4.34
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.31
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.28
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 4.27
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 4.26
Tracing Enhancer Networks using Epigenetic Traits (TENET) 4.18
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.12
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.11
RNA sequencing of mechanically strained NHEKs and control NHEKs 4.1
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 4.09
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 4.07
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.07
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 4.06
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.01
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.95
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 3.94
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.93
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.85
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.84
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 3.82
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.8
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.77
Loss of CREBBP results in gene expression repression in lymphoma cells 3.74
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 3.74
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.74
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 3.71
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 3.66
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.64
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.59
Gene expression patterns define the hepatocyte-like cells derived by different strategies 3.56
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 3.56
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.54
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 3.52
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 3.47
SLAM-seq for K562 endogenous mRNA decay 3.45
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 3.45
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.44
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.44
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 3.42
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.41
N6-methyladenine DNA Modification in Glioblastoma 3.4
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 3.4
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.37
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 3.35
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 3.32
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.29
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.29
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.19
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.19
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.18
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.17
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.16
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.16
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.15
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.14
Effect of PBK knockdown on C4-2 cell transcriptome 3.13
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 3.12
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 3.09
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.08
Gene expression in GBM with Cav3.2 inhibition 3.07
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.04
HEK293 TFAM Knockout Expression Study 2.91
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.9
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.9
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.9
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.89
Targeted enhancer activation by a subunit of the integrator complex 2.88
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 2.86
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.84
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.84
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.81
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 2.71
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 2.71
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 2.7
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.67
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.57
Genome-wide discovery of human splicing branchpoints 2.55
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.55
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.47
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.44
Downregulation of DDX5/DDX17 and REST 2.43
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 2.41
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.4
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.37
quanTIseq: quantifying immune contexture of human tumors 2.33
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 2.33
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 2.33
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.32
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.31
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.31
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.3
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 2.29
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.27
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.27
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.26
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.26
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 2.25
Patient-derived xenograft platform for metastatic melanoma 2.17
Metastasis in triple-negative breast cancer 2.16
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.16
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.16
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 2.14
Illumina Total RNA-seq in HeLa 2.14
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.12
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 2.12
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 2.12
nELAVL HITS-CLIP in Alzheimer's Disease patients 2.1
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.08
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.02
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 1.99
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.97
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 1.96
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 1.95
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.95
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 1.94
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.86
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.86
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.85
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.85
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 1.85
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 1.81
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Myc activation coordinates gene transcription and protein translation responses 1.76
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.76
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.76
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.75
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.75
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.73
Oncogenic MYC induces a dependency on the spliceosome in human cancer 1.63
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 1.63
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.6
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 1.59
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.59
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.59
Toxoplasma gondii infection of human retinal pigment epithelial cells 1.58
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.58
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.57
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.56
Differentiation enhances Zika virus infection in neuronal brain cells 1.55
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 1.52
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.49
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 1.49
Gene expression analysis of human adenomas. 1.43
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.41
Transcriptomic analysis of LSD1 1.41
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.4
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.4
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.38
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.33
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.33
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.33
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.33
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.31
Interphase condensins regulate ligand-depedent enhancer activation 1.31
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.29
Gene expression activation in CLL mediated by MSCs contact 1.29
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.24
A single-cell transcriptome atlas of the human pancreas 1.24
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.22
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.2
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 1.18
Human Tfh cell RNA bulk sequencing 1.15
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.13
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.05
Transposon-based construction of strand-specific RNA-seq libraries 1.03
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.02
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.02
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.99
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.98
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.97
The bromodomain protein BRD4 regulates splicing during heat shock 0.97
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.96
Anti-inflammatory effect of indoleacrylic acid (IA) 0.95
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.94
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 0.92
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.9
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.9
Transcriptome landscape of HeLa response upon triamcinolone acetonide 0.9
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.89
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.88
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.87
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 0.87
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 0.82
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 0.82
naive T cell heterogeneity after neonatal thymectomy 0.82
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.8
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.8
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.8
The pioneer factor CEBPA modulates vitamin D signaling 0.8
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.78
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 0.76
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.74
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.73
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 0.7
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 0.7
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.68
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.68
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.67
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 0.67
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 0.67
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.64
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.62
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.61
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 0.61
Functional significance of the HIV-1 Tat signature amino acid residues 0.56
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.56
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.56
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.55
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.53
The role of m6A/m-RNA methylation in stress response regulation 0.53
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.5
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.49
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.49
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 0.46
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.44
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.44
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.44
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.44
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.4
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.4
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.4
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.4
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.37
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.37
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.37
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.35
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.32
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.32
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.31
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.3
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.28
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.27
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.22
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 0.19
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.16
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.16
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.09
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.09
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.09
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.08
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.08
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.05
Function and hormonal regulation of GATA3 in human first trimester placentation 0.04
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 0.03
Recovery and analysis of nascent RNA 0.03
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.02
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.01
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation